Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis

Journal of Clinical Investigation

Volumn 123, Issue 12, 2013, Pages 5082-5097

  Nie, Lei ^a,b   Guo, Xiaojia ^a,b   Esmailzadeh, Leila ^a,b   Zhang, Jiasheng ^a,b   Asadi, Abolfazl ^a,b   Collinge, Mark ^b   Li, Xuan ^a,b   Kim, Jun Dae ^b   Woolls, Melissa ^b   Jin, Suk Won ^b   Dubrac, Alexandre ^b   Eichmann, Anne ^b,c   Simons, Michael ^b   Bender, Jeffrey R ^b   Sadeghi, Mehran M ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c l'alimentation et l'Environnement   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; ENDOTHELIAL AND SMOOTH MUSCLE CELL DERIVED NEUROPILIN LIKE PROTEIN; GENOMIC DNA; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPILIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PROTEIN TYROSINE PHOSPHATASE 1B; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ATTENUATION; CELL COUNT; CELL GROWTH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; GASTROCNEMIUS MUSCLE; GENE DELETION; GENE SILENCING; HOMOLOGOUS RECOMBINATION; IMMUNOFLUORESCENCE; IN VIVO STUDY; INDEL MUTATION; KNOCKOUT MOUSE; LETHALITY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ZEBRA FISH;

ANIMALS; ANTIGENS, CD; BLOOD VESSELS; CADHERINS; CELLS, CULTURED; EAR, EXTERNAL; ENDOTHELIUM, VASCULAR; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPILINS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; RETINAL VESSELS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84890040193     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67752     Document Type: Article

References (48)

1. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011;437(2):169-183.
2. Simons M. An inside view: VEGF receptor trafficking and signaling. Physiology (Bethesda). 2012; 27(4):213-222.
3. Sawamiphak S, et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 2010;465(7297):487-491.
4. Lanahan AA, et al. VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell. 2010;18(5):713-724.
5. Fantin A, Maden CH, Ruhrberg C. Neuropilin ligands in vascular and neuronal patterning. Biochem Soc Trans. 2009;37(pt 6):1228-1232.
6. Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J. 2008;411(2):211-226.
7. Gu C, et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell. 2003;5(1):45-57.
8. Prahst C, et al. Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. J Biol Chem. 2008;283(37):25110-25114.
9. Salikhova A, et al. Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res. 2008;103(6):e71-e79.
10. Kobuke K, et al. ESDN, a novel neuropilin-like membrane protein cloned from vascular cells with the longest secretory signal sequence among eukaryotes, is up-regulated after vascular injury. J Biol Chem. 2001;276(36):34105-34114.
11. Koshikawa K, et al. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo. Oncogene. 2002;21(18):2822-2828.
12. Sadeghi MM, et al. ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis. Am J Transplant. 2007;7(9):2098-2105.
13. Yu J, et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A. 2005;102(31):10999-z1004.
14. Gerhardt H, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161(6):1163-1177.
15. Alva JA, et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn. 2006;235(3):759-767.
16. Georgijevic S, Subramanian Y, Rollins EL, Starovic- Subota O, Tang AC, Childs SJ. Spatiotemporal expression of smooth muscle markers in developing zebrafish gut. Dev Dyn. 2007;236(6):1623-1632.
17. Santoro MM, Pesce G, Stainier DY. Characterization of vascular mural cells during zebrafish development. Mech Dev. 2009;126(8-9):638-649.
18. Eilken HM, Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol. 2010;22(5):617-625.
19. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011; 146(6):873-887.
20. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 2006;7(5):359-371.
21. Nakamura Y, et al. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells. Circ Res. 2008;102(10):1182-1191.
22. Mattila E, Auvinen K, Salmi M, Ivaska J. The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling. J Cell Sci. 2008;121(pt 21):3570-3580.
23. Baumer S, et al. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood. 2006;107(12):4754-4762.
24. Mellberg S, et al. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J. 2009;23(5):1490-1502.
25. Nakayama M, et al. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol. 2013;15(3):249-260.
26. Grazia Lampugnani M, et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP- 1/CD148. J Cell Biol. 2003;161(4):793-804.
27. Chabot C, Spring K, Gratton JP, Elchebly M, Royal I. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol Cell Biol. 2009;29(1):241-253.
28. Guo DQ, et al. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factorinduced endothelial cell proliferation. J Biol Chem. 2000;275(15):11216- 11221.
29. Gallicchio M, et al. Inhibition of vascular endothelial growth factor receptor 2-ediated endothelial cell activation by Axl tyrosine kinase receptor. Blood. 2005;105(5):1970-1976.
30. Lanahan A, et al. The neuropilin 1 cytoplasmic domain is required for VEGF-A- dependent arteriogenesis. Dev Cell. 2013;25(2):156-168.
31. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin 3 receptor. Cell. 1997;90(4):753-762.
32. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. The neuropilins: ultifunctional semaphoring and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med. 2002;12(1):13-19.
33. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signal-ing from intracellular compartments. J Cell Biol. 2006;174(4):593-604.
34. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735-745.
35. Stuible M, Tremblay ML. In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis. Trends Cell Biol. 2010;20(11):672-679.
36. Manickam V, et al. Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood. 2010;117(4):1425-1435.
37. Miyake S, Lupher ML Jr, Druker B, Band H. The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha. Proc Natl Acad Sci U S A. 1998;95(14):7927-7932.
38. Guo X, Nie L, Esmailzadeh L, Zhang J, Bender JR, Sadeghi MM. Endothelial and smooth musclederived neuropilin-like protein regulates plateletderived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination. J Biol Chem. 2009;284(43):29376-29382.
39. Duval M, Bedard-Goulet S, Delisle C, Gratton JP. Vascular endothelial growth factor- dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J Biol Chem. 2003;278(22):20091-20097.
40. Rahimi N. A role for protein ubiquitination in VEGFR-2 signalling and angiogenesis. Biochem Soc Trans. 2009;37(pt 6):1189-1192.
41. Sadeghi MM, et al. Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo. Circulation. 2004;110(1):84-90.
42. Zhang H, et al. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J Clin Invest. 2008;118(12):3904-3916.
43. Auerbach W, et al. Establishment and chimera analysis of 129/SvEv- and C57BL/6- derived mouse embryonic stem cell lines. Biotechniques. 2000;29(5):1024-1028
44. Leneuve P, et al. Cre-mediated germline mosaicism: a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles. Nucleic Acids Res. 2003;31(5):e21.
45. Zeng L, et al. Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc Natl Acad Sci U S A. 2009;106(20):8326-8331.
46. Smith NR, et al. Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts. Mol Cancer Ther. 2007;6(8):2198-2208.
47. Ackah E, et al. Akt1/protein kinase Balpha is critical for ischemic and VEGF-ediated angiogenesis. J Clin Invest. 2005;115(8):2119-2127.
48. Schmitt CE, Woolls MJ, Jin SW. Mutant-specific gene expression profiling identifies RY- related HMG box 11b (SOX11b) as a novel regulator of vascular development in zebrafish. Mol Cells. 2013;35(2):166-172.